Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Organon & Co. (OGN : NYSE)

• Company Description    Organon is a healthcare company. It focuses on the health of women throughout their lives. Organon is based in JERSEY CITY, N.J. Number of Employees: 9,300

• Price / Volume Information    Yesterday's Closing Price: $38.10 Daily Weekly Monthly 20 Day Moving Average: 1,795,747 shares Shares Outstanding: 253.64 (millions) Market Capitalization: $9,663.58 (millions) Beta: 52 Week High: $39.47 52 Week Low: $27.25 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 17.52% 23.58% 12 Week -3.20% 6.72% Year To Date 25.12% 49.89%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 30 Hudson Street FL 33 - Jersey City,NJ 07302 USA ph: 551-430-6900 fax: - investor_relations@organon.com http://www.organon.com

• General Corporate Information    Officers Kevin Ali - Chief Executive Officer Carrie Cox - Chairman of the Board of Directors Matthew Walsh - Chief Financial Officer Kathryn DiMarco - SVP Finance - Corporate Controller Robert Essner - Director Peer Information Organon & Co. (CHCR) Organon & Co. (ESRX) Organon & Co. (MYDP) Organon & Co. (GBCS) Organon & Co. (LAXAF) Organon & Co. (IPCM) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 68622V106 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/11/22 Share - Related Items Shares Outstanding: 253.64 Most Recent Split Date: (:1) Beta: Market Capitalization: $9,663.58 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 2.94% Current Fiscal Quarter EPS Consensus Estimate: $1.28 Indicated Annual Dividend: $1.12 Current Fiscal Year EPS Consensus Estimate: $5.34 Payout Ratio: 0.17 Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 05/13/2022 - $0.56 Next EPS Report Date: 08/11/22

• Fundamental Ratios P/E Current FY Estimate: 7.14 Trailing 12 Months: 5.94 PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: 5.20 Price / Sales: 1.52 EPS Growth vs. Year Ago Period: 5.77% vs. Previous Quarter: 20.44% Sales Growth vs. Year Ago Period: 4.05% vs. Previous Quarter: -2.31% ROE 03/31/22 - -103.33 12/31/21 - -1,899.41 09/30/21 - 98.08 ROA 03/31/22 - 14.98 12/31/21 - 15.08 09/30/21 - 15.55 Current Ratio 03/31/22 - 1.61 12/31/21 - 1.45 09/30/21 - 1.38 Quick Ratio 03/31/22 - 1.20 12/31/21 - 1.10 09/30/21 - 1.09 Operating Margin 03/31/22 - 25.60 12/31/21 - 25.46 09/30/21 - 25.85 Net Margin 03/31/22 - 20.42 12/31/21 - 21.43 09/30/21 - 24.03 Pre-Tax Margin 03/31/22 - 23.63 12/31/21 - 24.25 09/30/21 - 28.79 Book Value 03/31/22 - -4.93 12/31/21 - -5.95 09/30/21 - -6.38 Inventory Turnover 03/31/22 - 2.58 12/31/21 - 2.63 09/30/21 - 2.61 Debt-to-Equity 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Capital 03/31/22 - - 12/31/21 - - 09/30/21 - -

Powered by Zacks Investment Research ©